LivaNova (NASDAQ:LIVN) Hits New 52-Week Low - Here's What Happened

LivaNova PLC (NASDAQ:LIVN - Get Free Report)'s share price reached a new 52-week low on Thursday . The company traded as low as $32.48 and last traded at $35.72, with a volume of 1966943 shares traded. The stock had previously closed at $33.85.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on LIVN shares. StockNews.com upgraded LivaNova from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, March 25th. Stifel Nicolaus reduced their price target on LivaNova from $72.00 to $60.00 and set a "buy" rating on the stock in a research report on Wednesday, February 26th. Barclays lowered their price objective on LivaNova from $58.00 to $56.00 and set an "equal weight" rating for the company in a research report on Friday, March 7th. Mizuho cut their target price on shares of LivaNova from $70.00 to $60.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 26th. Finally, The Goldman Sachs Group decreased their price target on shares of LivaNova from $64.00 to $55.00 and set a "buy" rating for the company in a research note on Monday, March 3rd. Two analysts have rated the stock with a hold rating, five have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $61.17.

LivaNova Price Performance

The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87. The company's 50 day simple moving average is $41.10 and its 200 day simple moving average is $47.17. The company has a market capitalization of $1.93 billion, a PE ratio of 84.40 and a beta of 0.90.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Harbor Capital Advisors Inc. grew its stake in LivaNova by 101.3% during the 1st quarter. Harbor Capital Advisors Inc. now owns 84,913 shares of the company's stock worth $3,335,000 after buying an additional 42,728 shares during the last quarter. UMB Bank n.a. grew its position in shares of LivaNova by 340.5% during the first quarter. UMB Bank n.a. now owns 837 shares of the company's stock worth $33,000 after acquiring an additional 647 shares during the last quarter. GAMMA Investing LLC grew its position in shares of LivaNova by 2,299.7% during the first quarter. GAMMA Investing LLC now owns 8,759 shares of the company's stock worth $344,000 after acquiring an additional 8,394 shares during the last quarter. Central Pacific Bank Trust Division increased its holdings in shares of LivaNova by 7.0% in the 1st quarter. Central Pacific Bank Trust Division now owns 4,407 shares of the company's stock valued at $173,000 after acquiring an additional 290 shares during the period. Finally, Wellington Management Group LLP purchased a new stake in LivaNova in the 4th quarter valued at $8,897,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.